Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nihon Chouzai Co ( (JP:3341) ) has provided an announcement.
Nihon Chouzai Co., Ltd. has announced plans to convene an extraordinary general meeting of shareholders to discuss a share consolidation and amendments to the Articles of Incorporation, which will result in the delisting of its shares from the Tokyo Stock Exchange. This move is part of a broader strategy involving a tender offer by AP86 Co., Ltd. aimed at acquiring all company shares and making Nihon Chouzai a wholly-owned subsidiary, ultimately impacting its market presence and shareholder structure.
The most recent analyst rating on (JP:3341) stock is a Hold with a Yen3834.00 price target. To see the full list of analyst forecasts on Nihon Chouzai Co stock, see the JP:3341 Stock Forecast page.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. operates within the healthcare industry, focusing on pharmaceutical services and products. The company is listed on the Tokyo Stock Exchange Prime Market and is involved in providing pharmacy services and pharmaceutical distribution.
Average Trading Volume: 257,920
Technical Sentiment Signal: Buy
Current Market Cap: Yen113.3B
For an in-depth examination of 3341 stock, go to TipRanks’ Overview page.